{"name":"Twist Bioscience Corporation","slug":"twist","ticker":"TWST","exchange":"NASDAQ","domain":"twistbioscience.com","description":"Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for can","hq":"South San Francisco, CA","founded":2013,"employees":"979","ceo":"Emily Leproust","sector":"Synthetic Biology / Life Science Tools","stockPrice":53.73,"stockChange":-0.66,"stockChangePercent":-1.21,"marketCap":"$3.3B","metrics":{"revenue":409479008,"revenueGrowth":19.3,"grossMargin":52.1,"rdSpend":80285000,"netIncome":-77670000,"cash":183049000,"dividendYield":0,"peRatio":-26.2,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"Twist Bioscience Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Twist Bioscience reported its fourth quarter and full year 2023 financial results, with revenue of $123.4 million and a net loss of $43.4 million.","drugName":"","sentiment":"neutral"},{"date":"2023-11-15","type":"deal","headline":"Twist Bioscience Announces Collaboration with Merck to Develop Synthetic DNA-Based Therapies","summary":"Twist Bioscience announced a collaboration with Merck to develop synthetic DNA-based therapies for the treatment of various diseases.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-02-25","type":"deal","source":"simplywall.st","summary":"Twist Bioscience Expands Antibody Discovery With Invenra Bispecific Platform Deal - simplywall.st","headline":"Twist Bioscience Expands Antibody Discovery With Invenra Bispecific Platform Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPcWtzTXhwMmdCS3NXTXdxSVYweGpCVldCXzFpYndodUdBTmtSWElxZUtOb0NHZlVDR3VvTV9aSTZCYUpuUGdTVldCalFtYjZOTERSRkVWQWZUS05yRHpwSmtTTmdGQWxmZGtuT0FXV0gzVHpoTHBFa2ZGOU9UZ2JKY3htR2k2alN1bmFWWUZvdnVpbldXenVwUHpaeG5DNUhkQ1dPdXZXczdnQzVESWpFZUFYbTUwOE41?oc=5","date":"2026-02-18","type":"pipeline","source":"Business Wire","summary":"Twist Bioscience to Present at Upcoming Investor Conferences - Business Wire","headline":"Twist Bioscience to Present at Upcoming Investor Conferences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxNMWMyajlLZzNhMVZIeDVjbW1fNEJNRXY2RFRld1duWXpQRGJLLUgwZU9aQk00di13MUV6QXVYZkl1WlBuNWl6YVhnaTVpd3Q3RUdXZzFMbnZLTGpLdEVIRU5Xd2ZnWnJFeEZmVzFFaWJUYWs1WERyZnQ2RW5rZXZFSHI4dGdxVU1pTTlTZ196Y1BEVjE4STRXaFZDZjB3YXhNSTMyc2kyLVI4SlY2TlF6QmgyU0NtV012dFhaeTJQdGQ1SS1RZDhUeHZxT05ORWotT0FIeTIwQmZTLXJJT1HSAeMBQVVfeXFMTndILURhOEx6UjBNLWVtUmRpQmFOU3dESDdVaE1nR2RKeTc2VXB4M1U5emZfOGxyU0Q2RkFpNkFmTno4QnFtRnlHRFZUQ1dBOG10NVJQa3ZEQU1qb28xak5RZmNRNmhUWk4xUXZ0eUJUSGpBQ3VlMlZYdXR4aDVXTXhFQzlLTFVld3cwcVhUUDhiMGlvRjgyQmRudU9MZWJnRUQycVlBRlFRY2NjRHZRTldIUWhqOEpESkxnQkN3VEN2VElRemVaZlFWdFFSWThsRnVCV1lDMWZUYjQtNjhLUEtjLTg?oc=5","date":"2026-02-10","type":"pipeline","source":"simplywall.st","summary":"This Insider Has Just Sold Shares In Twist Bioscience - simplywall.st","headline":"This Insider Has Just Sold Shares In Twist Bioscience","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQQ2dRX2w3bHN5OFcxMFZEdEoydlFhYTlKY3J3Z2dac2pnbzFIVzRJdkdabWR2V2ROVHhLSUNudGVYUXVxX3ZWdFRUcDFTWHVWczZZclB2VG9mV3g1YkRMZFBCdGVWOERUTlduQkppYkN0ZGxGTUIxQUd0ZTRULUhlQ0VheWU5VGhjM1diSWhvVlZUcS1zcVBPWGxwRFU0Yk1mVDRzZC10VllWUUxi?oc=5","date":"2026-02-02","type":"pipeline","source":"Seeking Alpha","summary":"Twist Bioscience: Ingenious Product Still Lacks Compelling Use Cases (NASDAQ:TWST) - Seeking Alpha","headline":"Twist Bioscience: Ingenious Product Still Lacks Compelling Use Cases (NASDAQ:TWST)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOM1dnc1JENkg4Zm5xZ2pVbktrblBhUFpNd1pHQmFoUnlIZ0VabmdudU5tZU9rZ2RGdnBqNzZ1RXo3UjRKbHR4UkJhcTE4aUJyanAyS2VkTi1Jd2ZQSG5GeXhUQzVPUDdhaFZjRGdRWXV6czY5b1hEY2UzLVhqWkNyS2toUWxKN1djaW9LdQ?oc=5","date":"2026-02-02","type":"pipeline","source":"Yahoo Finance","summary":"Twist Bioscience Corporation (TWST): A Bull Case Theory - Yahoo Finance","headline":"Twist Bioscience Corporation (TWST): A Bull Case Theory","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-14","type":"pipeline","source":"simplywall.st","summary":"Twist Bioscience Corporation (NASDAQ:TWST) Held Back By Insufficient Growth Even After Shares Climb 30% - simplywall.st","headline":"Twist Bioscience Corporation (NASDAQ:TWST) Held Back By Insufficient Growth Even After Shares Climb 30%","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-22","type":"pipeline","source":"Insider Monkey","summary":"New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST) - Insider Monkey","headline":"New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQaFpkb0pRZ19QX1Znai1qV0lBRGNucVhRRHBPSWpid25jVWk3TkhvS2JLdGUtWC0xZk1LR0prZ3pyaldqZVJjUEwxdHV1V3UxUGkxbE1VdTQ4amtZZ1pNNjBYLTZsc2E0WTVTcGNYLWNFeHRWUlkwUWFYLXVNZ2tGNG5GZzhIMXFQS09rMFU3TEtsMHQ5TGRfZGlLSXhYVXBoelpYLU8weUx3ME5UTnJtN1JRWFVEZWFZNkVVYm5jMzI?oc=5","date":"2025-12-17","type":"pipeline","source":"TechStock²","summary":"Twist Bioscience (TWST) Stock News Today: Latest Catalysts, Analyst Forecasts, and 2026 Outlook (Dec. 17, 2025) - TechStock²","headline":"Twist Bioscience (TWST) Stock News Today: Latest Catalysts, Analyst Forecasts, and 2026 Outlook (Dec. 17, 2025) - TechSt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxOdkVFbVlPdHp6elo0RXNtclUtYVZ0LXlTYmJkUmJxS1FpMElmd1dYdmxybmhHY3F1SjZFLVJib0E5MmVaZkJkNzBXMGdtM1hMODBDMjNJellVOUhaZDhtTi1JYl9ZUWRRaDlIRGstVWl2NGUxa2RFWTVUcnBaOE01d1R4LTBDdmdEd3F1OUV0MW0yWUdnNy1uWXVRZjhTcmJXMHZMZFRNUU9vQTFlWW5SV1puS3J4ZzRyUzdYVWhFTURhMlBkQkhNX1FucGd1NnZ1REdEYXhkc0MxUTVxNWc?oc=5","date":"2025-12-04","type":"pipeline","source":"Business Wire","summary":"Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research - Business Wire","headline":"Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOVlhYU21JMVlBR21aX01SbU1tWUpCVkhUNUpLTlZTT3JHTmFIaFBUb0YyZzBRN096OW9XZzZxUlNwRzZlVEtLZ1M3UHV2YmF3c0dTUjZBTHRkS1FaVzV0VlB4aktqOW93MTFqR290NGJYUmtNbDBoOHpSRGJsWlNSQTJHTFVBb3BjODkwSA?oc=5","date":"2025-09-18","type":"pipeline","source":"Yahoo Finance","summary":"3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025 - Yahoo Finance","headline":"3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPQ0kxZ1REUXczTndsVVVXLUhDNTJIOWR3VGpqZVRfeEZBSUlqTWpFS3RJamJVYWp3RUxGcEM3UUxTYk5ZS2tUbUFEeklWMWpsOS1mRU5MODZNUDF1Z1YzYVdyT1p4SFVQV05CUWY5bmVCU1hfdWZQX0ZMUWFaTldZQWZaYV9hUjZPVGlxQ2VjVmFkMWpBc0Nta2M0M2ZjVHpybjE5RXJvc29RcnQ3anBuaTB0NkthQQ?oc=5","date":"2025-05-01","type":"earnings","source":"Seeking Alpha","summary":"Twist Bioscience Q2 Earnings Preview: Innovative Products, Not Enough Buyers - Seeking Alpha","headline":"Twist Bioscience Q2 Earnings Preview: Innovative Products, Not Enough Buyers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE1fWmZnaU95c0NtSDBCODRvQ21ZWjhJcm9QeGdCUm44bFJtV0NpYnQwY1hHdXA5eUVXb3cyX2tJa3kxTEd3b1NfdkVzckRnQ3JYLVNMM1RTRzlzWFhXdEM3UnVzYlp0M1F1TFpONGFuN1J2a0F4?oc=5","date":"2025-03-09","type":"pipeline","source":"Nanalyze","summary":"Twist Bioscience Defies Skeptics With Strong Growth - Nanalyze","headline":"Twist Bioscience Defies Skeptics With Strong Growth","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Pacific Biosciences of California, Inc.","Illumina, Inc.","Thermo Fisher Scientific Inc."],"therapeuticFocus":["Synthetic Biology","Gene Editing"],"financials":{"source":"sec_edgar+yahoo","revenue":376572000,"revenuePeriod":"2025-09-30","revenueHistory":[{"period":"2025-09-30","value":376572000},{"period":"2024-09-30","value":312974000},{"period":"2023-09-30","value":245109000},{"period":"2022-09-30","value":203565000}],"grossProfit":191002000,"grossProfitHistory":[{"period":"2025-09-30","value":191002000},{"period":"2024-09-30","value":133349000},{"period":"2023-09-30","value":89729000},{"period":"2022-09-30","value":84235000}],"rdSpend":80285000,"rdSpendHistory":[{"period":"2025-09-30","value":80285000},{"period":"2024-09-30","value":90852000},{"period":"2023-09-30","value":106894000},{"period":"2022-09-30","value":120307000}],"sgaSpend":246976000,"operatingIncome":-136259000,"operatingIncomeHistory":[{"period":"2025-09-30","value":-136259000},{"period":"2024-09-30","value":-175901000},{"period":"2023-09-30","value":-206903000},{"period":"2022-09-30","value":-249021000}],"netIncome":-77670000,"netIncomeHistory":[{"period":"2025-09-30","value":-77670000},{"period":"2024-09-30","value":-208726000},{"period":"2023-09-30","value":-204618000},{"period":"2022-09-30","value":-217863000}],"eps":-1.3,"epsHistory":[{"period":"2025-09-30","value":-1.3},{"period":"2024-09-30","value":-3.6},{"period":"2023-09-30","value":-3.6},{"period":"2022-09-30","value":-4.04}],"cash":183049000,"cashHistory":[{"period":"2025-09-30","value":183049000},{"period":"2024-09-30","value":226316000},{"period":"2023-09-30","value":286470000},{"period":"2022-09-30","value":378687000}],"totalAssets":641861000,"totalLiabilities":168903000,"totalDebt":75572000,"equity":472958000,"operatingCashflow":-47628000,"operatingCashflowHistory":[{"period":"2025-09-30","value":-47628000},{"period":"2024-09-30","value":-64094000},{"period":"2023-09-30","value":-142474000},{"period":"2022-09-30","value":-124385000}],"capex":-28004000,"capexHistory":[{"period":"2025-09-30","value":-28004000},{"period":"2024-09-30","value":-5076000},{"period":"2023-09-30","value":-27779000},{"period":"2022-09-30","value":-101857000}],"freeCashflow":-75632000,"dividendsPaid":null,"buybacks":-16000,"employees":979,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":76085000,"ebit":-38658000,"ebitda":-32244000,"period":"2026-03-31","revenue":110715000,"epsBasic":-0.71,"netIncome":-44021000,"rdExpense":19695000,"epsDiluted":-0.71,"grossProfit":57122000,"operatingIncome":-38658000},{"sga":69942000,"ebit":-33100000,"ebitda":-26906000,"period":"2025-12-31","revenue":103698000,"epsBasic":-0.5,"netIncome":-30507000,"rdExpense":17130000,"epsDiluted":-0.5,"grossProfit":53972000,"operatingIncome":-33100000},{"sga":63757000,"ebit":-29934000,"ebitda":-23930000,"period":"2025-09-30","revenue":99009000,"epsBasic":-0.45,"netIncome":-27138000,"rdExpense":17014000,"epsDiluted":-0.45,"grossProfit":50837000,"operatingIncome":-29934000},{"sga":63370000,"ebit":-30120000,"ebitda":-24055000,"period":"2025-06-30","revenue":96057000,"epsBasic":0.34,"netIncome":20390000,"rdExpense":18047000,"epsDiluted":0.33,"grossProfit":51297000,"operatingIncome":-30120000},{"sga":63671000,"ebit":-41560000,"ebitda":-35156000,"period":"2025-03-31","revenue":92793000,"epsBasic":-0.66,"netIncome":-39328000,"rdExpense":23917000,"epsDiluted":-0.66,"grossProfit":46028000,"operatingIncome":-41560000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-12-31","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":53.73,"previousClose":54.39,"fiftyTwoWeekHigh":66.06,"fiftyTwoWeekLow":23.3,"fiftyTwoWeekRange":"23.3 - 66.06","fiftyDayAverage":52.1,"twoHundredDayAverage":38.31,"beta":2.23,"enterpriseValue":3326106880,"forwardPE":-26.2,"priceToBook":7.34,"priceToSales":8.17,"enterpriseToRevenue":8.12,"enterpriseToEbitda":-30.28,"pegRatio":0,"ebitda":-109835000,"ebitdaMargin":-26.8,"freeCashflow":-58482500,"operatingCashflow":-55587000,"totalDebt":110841000,"debtToEquity":24.4,"currentRatio":2.7,"returnOnAssets":-12.9,"returnOnEquity":-18.2,"analystRating":"1.3 - Strong Buy","recommendationKey":"strong_buy","numberOfAnalysts":9,"targetMeanPrice":63.33,"targetHighPrice":75,"targetLowPrice":36,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":1.3,"institutionHeldPercent":117.3,"sharesOutstanding":62271314,"floatShares":55417110,"sharesShort":13914949,"shortRatio":11.01,"shortPercentOfFloat":22.4,"epsTrailing":-1.32,"epsForward":-2.05,"revenuePerShare":6.74,"bookValue":7.32,"officers":[{"age":52,"name":"Dr. Emily Marine Leproust Ph.D.","title":"Co-Founder, Board Chair & CEO"},{"age":53,"name":"Dr. Patrick John Finn Ph.D.","title":"President & COO"},{"age":48,"name":"Mr. Adam  Laponis","title":"Chief Financial Officer"},{"age":54,"name":"Mr. Dennis  Cho J.D.","title":"Chief Legal Officer & Corporate Secretary"},{"age":57,"name":"Ms. Paula  Green","title":"Senior Vice President of Human Resources"},{"age":52,"name":"Mr. Robert F. Werner","title":"VP & Chief Accounting Officer"},{"age":null,"name":"Mr. Siyuan  Chen","title":"Chief Technology Officer"},{"age":null,"name":"Dr. Michael  Fero Ph.D.","title":"Chief Information Officer"}],"industry":"Diagnostics & Research","irWebsite":"","website":"https://www.twistbioscience.com","phone":"800 719 0671"}}